Soluble Urokinase-Type Plasminogen Activator Receptor Levels in Patients With Schizophrenia

Background: The etiology of schizophrenia remains largely unknown but alterations in the immune system may be involved. In addition to the psychiatric symptoms, schizophrenia is also associated with up to 20 years reduction in life span. Soluble urokinase-type plasminogen activator receptor (suPAR)...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Schizophr Bull
Glavni autori: Nielsen, Jimmi, Røge, Rasmus, Pristed, Sofie Gry, Viuff, Anne Grethe, Ullum, Henrik, Thørner, Lise Wegner, Werge, Thomas, Vang, Torkel
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2015
Teme:
Regular Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4393680/
https://ncbi.nlm.nih.gov/pubmed/25154621
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbu118
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items